The Generic Pharmaceutical Association says that savings from the use of generic prescription drugs has risen to the rate of nearly $1 billion every two days, totaling $193 billion in 2011 and more than $1 trillion in the last decade.
The GPhA commissioned the IMS Institute for Healthcare Informatics, a division of IMS Health, for an independently conducted study, which showed generic savings for consumers and the U.S. health care system grew 22% from 2010 to last year, the largest single-year jump since 1998.
